[HTML][HTML] Recent developments in adenosine receptor ligands and their potential as novel drugs

CE Müller, KA Jacobson - Biochimica et Biophysica Acta (BBA) …, 2011 - Elsevier
Medicinal chemical approaches have been applied to all four of the adenosine receptor
(AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each …

Adenosine A2A Receptor as a Drug Discovery Target

M de Lera Ruiz, YH Lim, J Zheng - Journal of medicinal chemistry, 2014 - ACS Publications
The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been
extensively studied during the past few decades because it offers numerous possibilities for …

Thiazole: A promising heterocycle for the development of potent CNS active agents

CB Mishra, S Kumari, M Tiwari - European journal of medicinal chemistry, 2015 - Elsevier
Thiazole is a valuable scaffold in the field of medicinal chemistry and has accounted to
display a variety of biological activities. Thiazole and its derivatives have attracted …

Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies

I Waku, MS Magalhaes, CO Alves… - European Journal of …, 2021 - Wiley Online Library
Several useful animal models for parkinsonism have been developed so far. Haloperidol‐
induced catalepsy is often used as a rodent model for the study of motor impairments …

History and Perspectives of A2A Adenosine Receptor Antagonists as Potential Therapeutic Agents

D Preti, PG Baraldi, AR Moorman… - Medicinal research …, 2015 - Wiley Online Library
Growing evidence emphasizes that the purine nucleoside adenosine plays an active role as
a local regulator in different pathologies. Adenosine is a ubiquitous nucleoside involved in …

Adenosine A2A Receptor Antagonists and Parkinson's Disease

BC Shook, PF Jackson - ACS chemical neuroscience, 2011 - ACS Publications
This Review summarizes and updates the work on adenosine A2A receptor antagonists for
Parkinson's disease from 2006 to the present. There have been numerous publications …

[HTML][HTML] Multitarget action of Benzothiazole-piperazine small hybrid molecule against Alzheimer's disease: In silico, In vitro, and In vivo investigation

CB Mishra, S Shalini, S Gusain, P Kumar… - Biomedicine & …, 2024 - Elsevier
A novel small molecule based on benzothiazole-piperazine has been identified as an
effective multi-target-directed ligand (MTDL) against Alzheimer's disease (AD). Employing a …

Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification

Z Zhong, X He, J Ge, J Zhu, C Yao, H Cai, XY Ye… - European Journal of …, 2022 - Elsevier
Parkinson's disease (PD) is the second common neurodegenerative disease characterized
by movement disorder. The symptoms of PD harm both the physical and mental health of …

Thione derivatives as medicinally important compounds

A Das, MW Ashraf, BK Banik - ChemistrySelect, 2021 - Wiley Online Library
Like nitrogen‐containing heterocycles, sulfur‐containing heterocyclic compounds also have
a lot of significant applications. These sulfur heterocycles are mainly used as a core for the …

Anti‐inflammatory Effects of S. cumini Seed Extract on Gelatinase‐B (MMP‐9) Regulation against Hyperglycemic Cardiomyocyte Stress

N Atale, CB Mishra, S Kohli, RK Mongre… - Oxidative Medicine …, 2021 - Wiley Online Library
Black berry (Syzygium cumini) fruit is useful in curing diabetic complications; however, its
role in diabetes‐induced cardiomyopathy is not yet known. In this study, we investigated the …